Policy | August 16, 2021
India restricts export of Rapid Antigen Test Kits used to detect Covid 19
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin
Fitterfly has launched an online Prediabetes risk test which is an evidence-based, clinically validated tool for assessing an individual's risk of Prediabetes
Demand normalisation post the second wave contributed to the steady growth
A globally approved pen filled by mass technology provides a safer self- administration fertility solution
Filing for WHO Emergency Use Authorisation this month
Board declares interim dividend of Rs 2 per equity share
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
PAT rises to Rs 195.76 crore
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Subscribe To Our Newsletter & Stay Updated
